Do I Need Hydroxyurea for S-HPFH?
At a Glance
Most patients with Sickle Cell-Hereditary Persistence of Fetal Hemoglobin (S-HPFH) do not need hydroxyurea. Your body naturally produces high levels of fetal hemoglobin, which prevents cell sickling. Hydroxyurea is typically unnecessary unless you experience frequent or severe pain crises.
If you have Sickle Cell-Hereditary Persistence of Fetal Hemoglobin (S-HPFH) and are feeling fine, you most likely do not need hydroxyurea. Standard severe sickle cell treatments like hydroxyurea are generally not indicated for asymptomatic S-HPFH because your body naturally produces sufficient fetal hemoglobin (HbF) to protect your red blood cells [1][2][3].
Important Safety Warning: If you are already taking hydroxyurea, never stop taking it without first consulting a sickle cell specialist. If your initial diagnosis was misunderstood and you actually have severe sickle cell anemia with naturally elevated HbF rather than true S-HPFH, abruptly stopping your medication could trigger a severe and dangerous sickle cell crisis.
How Hydroxyurea Works (And Why You May Not Need It)
In classic sickle cell anemia (HbSS), red blood cells become hard and sticky because of a mutated protein called sickle hemoglobin (HbS). Hydroxyurea is a daily medication prescribed to modify the disease by forcing the body to produce more fetal hemoglobin, a healthy type of hemoglobin that stops cells from sickling [2][4].
However, patients with S-HPFH naturally maintain high levels of fetal hemoglobin—often between 20% and 45% of their total hemoglobin [1]. More importantly, this fetal hemoglobin is distributed evenly across almost all of your red blood cells (a pattern called pancellular distribution), which acts as a built-in shield against the sickling process [5][6]. Because your body is already doing exactly what hydroxyurea is designed to do, taking the medication offers little to no additional benefit for an asymptomatic person [2][3].
Why Your Doctor Might Have Prescribed It
It is common for doctors who do not specialize in sickle cell genetics to misinterpret S-HPFH [7][8]. Basic blood screening tests (like hemoglobin electrophoresis) look for the presence of different hemoglobins. Because S-HPFH blood lacks normal adult hemoglobin (HbA) and contains mostly sickle hemoglobin (HbS) alongside the high HbF, your test results look almost identical to severe classic sickle cell anemia (HbSS) to an untrained eye [8]. A non-specialist might automatically flag you as having the severe form of the disease and follow standard guidelines to prescribe hydroxyurea [7]. They may not realize that the genetic trait for HPFH completely changes your diagnosis and risk level [5][9].
While people with S-HPFH generally have a very mild clinical course, you could still occasionally experience mild pain crises, particularly if triggered by extreme physical stress, severe dehydration, or high altitudes [1][10]. In rare cases where a patient with S-HPFH experiences frequent or severe acute pain events, a specialist might then evaluate if additional treatments are necessary. For the vast majority of patients, however, symptoms remain mild and hydroxyurea is not needed [1].
How to Advocate for Yourself
You have the right to question treatments that do not align with your specific diagnosis. If a doctor recommends hydroxyurea and you have S-HPFH without symptoms, you can protect yourself from unnecessary interventions by taking these steps:
- Share your genetic test results: The gold standard for proving you have S-HPFH rather than classic sickle cell anemia is a genetic DNA test, often called gap-PCR (which detects the most common “deletional” types of HPFH) or advanced gene sequencing (for “non-deletional” types) [11]. Bring these records to every new doctor.
- Explain your baseline: Remind the doctor that you have S-HPFH, meaning your blood naturally maintains high, pancellular fetal hemoglobin levels that protect you from typical sickle cell complications.
- Maintain a relationship with a specialist: Even though your condition is mild, it is important to establish a baseline with a hematologist who specializes in sickle cell genetics. They can perform routine check-ups, ensure your medical records are accurate, and be your advocate if another doctor tries to prescribe unnecessary medications.
Common questions in this guide
Why do doctors sometimes prescribe hydroxyurea for S-HPFH?
How does fetal hemoglobin protect against sickle cell?
What test confirms an S-HPFH diagnosis?
Can I stop taking hydroxyurea if I think I have S-HPFH?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can you review my genetic testing results (such as gap-PCR) to confirm my specific diagnosis of S-HPFH rather than classic HbSS?
- 2.Given that my body naturally produces high levels of pancellular fetal hemoglobin, what specific clinical benefit do you believe hydroxyurea will provide me?
- 3.Are you recommending hydroxyurea because of standard guidelines for sickle cell disease, or did a specific symptom or lab result of mine prompt this suggestion?
- 4.Can you refer me to a hematologist or sickle cell specialist to manage my routine care and confirm any changes to my treatment plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
The Natural History of Hb S/Hereditary Persistence of Fetal Hemoglobin in 13 Children from the State of Minas Gerais, Brazil.
Belisário AR, Sales RR, Silva CM, et al.
Hemoglobin 2016; (40(3)):215-9 doi:10.3109/03630269.2016.1149076.
PMID: 27117574 - 2
Impact of Hydroxyurea on Clinical and Biological Parameters of Sickle Cell Anemia in Children in Abidjan.
Yayo-Aye M, Adjambri AE, Kouakou B, et al.
Mediterranean journal of hematology and infectious diseases 2024; (16(1)):e2024026 doi:10.4084/MJHID.2024.026.
PMID: 38468842 - 3
Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy.
Dhar A, Leung TM, Appiah-Kubi A, et al.
Blood advances 2021; (5(21)):4406-4412 doi:10.1182/bloodadvances.2021005076.
PMID: 34529023 - 4
Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.
Egesa WI, Nakalema G, Waibi WM, et al.
International journal of pediatrics 2022; (2022()):3885979 doi:10.1155/2022/3885979.
PMID: 36254264 - 5
Sickle cell disease severity: an introduction.
Pace BS, Goodman SR
Experimental biology and medicine (Maywood, N.J.) 2016; (241(7)):677-8 doi:10.1177/1535370216641880.
PMID: 27190296 - 6
Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell disease.
Henry ER, Cellmer T, Dunkelberger EB, et al.
Proceedings of the National Academy of Sciences of the United States of America 2020; (117(26)):15018-15027 doi:10.1073/pnas.1922004117.
PMID: 32527859 - 7
Blessing in disguise; a case of Hereditary Persistence of Fetal Hemoglobin.
Shaukat I, Pudal A, Yassin S, et al.
Journal of community hospital internal medicine perspectives 2018; (8(6)):380-381 doi:10.1080/20009666.2018.1536241.
PMID: 30559951 - 8
Microcytosis Merits Evaluation: A Case Report of Hemoglobin S With Hereditary Persistence of Fetal Hemoglobin (HbS-HPFH Syndrome).
Daniel CE, Bejjani A
Cureus 2025; (17(2)):e78827 doi:10.7759/cureus.78827.
PMID: 40084327 - 9
Phenotypic variation in sickle cell disease: the role of beta globin haplotype, alpha thalassemia, and fetal hemoglobin in HbSS.
Serjeant GR
Expert review of hematology 2022; (15(2)):107-116 doi:10.1080/17474086.2022.2040984.
PMID: 35143361 - 10
A Rare Case of Multiple Bone Infarctions and Abnormal Pulmonary Function Tests in a Patient With Compound Heterozygous Hemoglobin S and Type 2 Hereditary Persistence of Fetal Hemoglobin.
Alnaqbi KA
Cureus 2024; (16(8)):e66395 doi:10.7759/cureus.66395.
PMID: 39113817 - 11
A Plea for the Newborn Diagnosis of Hb S-Hereditary Persistence of Fetal Hemoglobin.
Serjeant GR, Serjeant BE, Hambleton IR, et al.
Hemoglobin 2017; (41(3)):216-217 doi:10.1080/03630269.2017.1360336.
PMID: 28870138
This information is for educational purposes and should not replace advice from a hematologist. Never stop taking prescribed hydroxyurea without consulting a sickle cell specialist.
Get notified when new evidence is published on Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.